AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2017

Mar 14, 2017

30198_dirs_2017-03-14_c1ff8267-ddcd-418c-8a2f-de267d8c5c5b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2017-03-10

Reporting Person: ROPER JESS (SVP, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-10	Common Stock	D	2538	$77.5506	Disposed	53565	Direct
2017-03-10	Common Stock	D	1948	$77.5506	Disposed	51617	Direct
2017-03-10	Common Stock	D	5120	$77.5506	Disposed	46497	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10452	Indirect

Footnotes

F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.

F2: Included in this number are 33,333 unvested restricted stock units, 20,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019 and 13,333 of which were granted on March 8, 2015 and shall vest through March 8, 2018.